Bank Of America Corp Bio Path Holdings Inc Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.36 - $0.75 $1,118 - $2,330	-3,107 Reduced 95.34%	152 $0
Q1 2023 May 12, 2023	BUY	$1.39 - $2.26 $4,306 - $7,001	3,098 Added 1924.22%	3,259 $4,000
Q4 2022 Feb 10, 2023	BUY	$1.32 - $69.2 $11 - $622	9 Added 5.92%	161 $0
Q3 2022 Nov 14, 2022	BUY	$3.18 - $66.0 $413 - $8,580	130 Added 590.91%	152 $0
Q3 2021 Nov 15, 2021	SELL	$5.13 - $6.78 $318 - $420	-62 Reduced 73.81%	22 $0
Q2 2021 Sep 13, 2021	BUY	$5.13 - $7.63 $430 - $640	84 New	84 $0

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $6.37M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.